Os arqt will up today?

**It is not possible to predict with certainty whether Arcutis Biotherapeutics (ARQT) will experience an increase in stock price today.** Here's an analysis based on the available information:

1. **Short Interest Update**: The short interest in Arcutis Biotherapeutics has seen a significant decline, with a 18.0% reduction from 26,020,000 shares to 21,340,000 shares. This reduction in short interest could indicate a positive sentiment among investors, which might potentially lead to an increase in stock price.
2. **Financial Performance**: Arcutis has shown strong financial performance, with a 675% increase in Q1 2024 net product revenues for ZORYVE cream 0.3% and a 59% sequential growth. The company's robust growth and positive developments, such as the FDA approval for the treatment of atopic dermatitis, could contribute to an increase in stock price.
3. **Market Sentiment**: The overall market sentiment towards Arcutis has been positive, with analysts reiterating their buy rating and setting a target price of $18.00. This positive sentiment could potentially lead to an increase in stock price.
4. **Industry and Market Conditions**: The medical dermatology industry, where Arcutis operates, is a sector with potential for significant growth. The company's focus on developing innovative treatments for immune-mediated dermatological diseases and conditions positions it well within a growing market, which could contribute to an increase in stock price.

While there are indicators that could suggest an increase in Arcutis Biotherapeutics' stock price, it's important to remember that stock prices are influenced by a multitude of factors, including market conditions, investor sentiment, and broader economic trends. Therefore, it's always advisable to conduct a comprehensive analysis that considers all relevant factors before making investment decisions.